HI HCR6

Urges Hawaii's congressional delegation to monitor the case Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration pending in U.S. District Court for the Northern District of Texas (Case No. 2:22-cv-00223-Z).

Expresses concern that a ruling in the Alliance case could ban mifepristone nationwide and prevent healthcare providers from prescribing it even in states where abortion is legal.

Notes mifepristone was FDA-approved on September 28, 2000, for use with misoprostol for medical termination of pregnancy through seven weeks gestation, extended to ten weeks gestation in 2016.

Requests Hawaii's congressional delegation take action to limit the case from further restricting access to safe abortion options.

Directs certified copies of the concurrent resolution be transmitted to members of Hawaii's congressional delegation.